SCPS — Scopus Biopharma Cashflow Statement
0.000.00%
Last trade - 00:00- $0.00m
- -$1.41m
Annual cashflow statement for Scopus Biopharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.686 | -2.69 | -10.9 | -27 | -11.7 |
| Depreciation | |||||
| Non-Cash Items | 0.07 | 0.214 | 7.19 | 12.7 | 0.352 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.131 | 0.355 | 1.15 | 2.84 | 3.23 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -0.747 | -2.12 | -2.53 | -11.4 | -8.13 |
| Capital Expenditures | — | -0.004 | 0 | -0.002 | -0.002 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | — | -0.004 | 0 | -0.002 | -0.002 |
| Financing Cash Flow Items | 0.035 | -0.452 | -1.11 | -2.44 | 0.242 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.598 | 2.18 | 4.35 | 17.6 | 0.242 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.157 | 0.035 | 1.8 | 6.11 | -7.82 |